Product Information
ENOXAPARIN 120 MG/0.8 ML SYR is a generic product labeled by Hepalink USA Inc., priced at $10.4173 per ML under NDC 81952013228. Its NADAC has been published 176 times since May 24, 2023.
FDA first approved this application on Mar 15, 2023. Its Orange Book therapeutic-equivalence code is AP.
Strength
120 mg/.8mL
Manufacturer
Hepalink USA Inc.NDC
81952013228
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
ENOXAPARIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA205660FDA Approved
3/15/2023
TE Code
AP
On Market Since
3/15/2023
Pharmacological Classes
Price Statistics
The NADAC for ENOXAPARIN 120 MG/0.8 ML SYR has been published 176 times since May 24, 2023, and over the history we have for it it has declined 22.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.4173 per ML |
|---|---|
| All-time high | $18.2233 (Feb 14, 2024) |
| All-time low | $9.5363 (Nov 20, 2024) |
| 52-week high | $14.0671 |
| 52-week low | $10.4173 |
| Median price | $13.4436 |
| Average price | $13.7641 |
| Largest weekly change | -39.1% (Nov 20, 2024) |
| Weeks tracked | 176 |
| Tracking since | May 24, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hepalink USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Enoxaparin Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Low Molecular Weight Heparin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENOXAPARIN 120 MG/0.8 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 120 MG/0.8 ML SYR, manufactured by Hepalink USA Inc., is $10.4173 per ML (NDC 81952013228), effective Sep 30, 2026.
How has the price of ENOXAPARIN 120 MG/0.8 ML SYR changed over time?
Over the history we have for it, the NADAC for ENOXAPARIN 120 MG/0.8 ML SYR has declined 22.7%. It has been tracked across 176 weekly CMS publications since May 24, 2023.
What are the highest and lowest recorded NADAC prices for ENOXAPARIN 120 MG/0.8 ML SYR?
Since May 24, 2023, the NADAC for ENOXAPARIN 120 MG/0.8 ML SYR has ranged from a low of $9.5363 (Nov 20, 2024) to a high of $18.2233 (Feb 14, 2024), with a median of $13.4436 per ML.
Are there cheaper alternatives to ENOXAPARIN 120 MG/0.8 ML SYR?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENOXAPARIN 120 MG/0.8 ML SYR in a comparable dosage form, but none are currently priced below it.
Who manufactures ENOXAPARIN 120 MG/0.8 ML SYR?
ENOXAPARIN 120 MG/0.8 ML SYR (NDC 81952013228) is labeled by Hepalink USA Inc., and CMS classifies it as a generic product.